Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
- Status
- WITHDRAWN
- Phase
- PHASE1
Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality
- Status
- COMPLETED
- Phase
- PHASE2
Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- NA
Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
- Status
- TERMINATED
- Phase
- N/A
Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.
- Status
- COMPLETED
- Phase
- PHASE2
Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
- Status
- UNKNOWN
- Phase
- N/A
RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts
- Status
- TERMINATED
- Phase
- PHASE3
Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2